In:
BMJ Supportive & Palliative Care, BMJ
Kurzfassung:
End of life has unacceptable levels of hospital admission and death. We aimed to determine the association of a novel digital specific system (Proactive Risk-Based and Data-Driven Assessment of Patients at the End of Life, PRADA) to modify such events. Methods A cohort-controlled study of those discharged alive, who died within 90 days of discharge, comparing PRADA (n=114) with standard care (n=3730). Results At 90 days, the PRADA group were more likely to die (78.9% vs 46.2%, p 〈 0.001), had a shorter time to death (58±90 vs 178±186 days, p 〈 0.001) but readmission (20.2% vs 37.9%, p 〈 0.001) or death in hospital (4.4% vs 28.9%, p 〈 0.001) was lower with reduced risk for a combined 90-day outcome of postdischarge non-elective admission or hospital death (OR 0.45, 95% CI 0.27–0.74, p 〈 0.001). Tightening criteria with 1:1 matching (n=83 vs 83) showed persistent significant findings in PRADA contact with markedly reduced adverse events (OR 0.15, 95% CI 0.02–0.96, p 〈 0.05). Conclusions Being seen in hospital by a specialist palliative care team using the PRADA tool was associated with significantly improved postdischarge outcomes pertaining to those destined to die after discharge.
Materialart:
Online-Ressource
ISSN:
2045-435X
,
2045-4368
DOI:
10.1136/spcare-2023-004474
Sprache:
Englisch
Verlag:
BMJ
Publikationsdatum:
2023